TCRTAlaunos Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Alaunos Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCRTThis | $5M#8 | — | 7.5x#13 | 973.0x#6 | -50.0%#6 | 10.8%#10 | -84500.0%#6 | -640.5%#13 | — | — | -30.9%#1 | — |
| APRE | $6M#1 | — | 0.2x#1 | — | — | 2.8%#11 | — | -32.8%#2 | — | — | -65.4%#2 | — |
| ALZN | $6M#2 | — | 1.0x#10 | — | — | -94.3%#15 | — | -151.2%#7 | — | — | — | — |
| PRPH | $6M#3 | — | — | 1.3x#2 | -35.8%#5 | 72.4%#2 | -415.4%#3 | — | -804.6%#4 | — | — | — |
| ACXP | $5M#4 | — | 0.7x#6 | — | — | 43.5%#5 | — | -97.7%#4 | — | — | — | — |
| PULM | $5M#5 | — | 2.1x#12 | 0.7x#1 | 7.0%#4 | 46.0%#4 | -66.2%#1 | -201.9%#8 | -235.7%#2 | — | — | — |
| PCSA | $5M#6 | 2.8x#3 | — | — | — | -14.5%#12 | — | — | — | — | — | 0.8%#1 |
| IMNN | $5M#7 | — | — | — | — | — | — | — | — | — | — | — |
| XBIO | $5M#9 | — | 0.8x#7 | 1.6x#4 | 19.0%#3 | 32.3%#8 | -95.2%#2 | -44.1%#3 | -1516.8%#6 | 4#1 | — | — |
| RVPH | $5M#10 | — | 0.3x#2 | — | — | 33.6%#7 | — | -130.6%#6 | — | — | — | — |
| TRAW | $4M#11 | — | 0.4x#5 | 1.6x#3 | 1134.5%#1 | 105.5%#1 | -640.7%#4 | 79.2%#1 | — | — | -88.5%#4 | — |
| CVKD | $4M#12 | — | 1.0x#9 | — | — | -24.3%#13 | — | -323.5%#11 | -585.1%#3 | — | — | — |
| ERNA | $3M#13 | 0.0x#2 | 1.1x#11 | 5.9x#5 | 755.9%#2 | 68.4%#3 | -1601.2%#5 | -440.1%#12 | -1016.2%#5 | — | — | — |
| GRI | $3M#14 | — | 0.3x#3 | — | -100.0%#7 | -45.7%#14 | — | -116.3%#5 | — | — | -96.7%#5 | — |
| KALA | $3M#15 | 0.0x#1 | 0.4x#4 | — | — | 29.9%#9 | — | -298.3%#10 | -69.9%#1 | — | — | — |
| DRMA | $3M#16 | — | 0.9x#8 | — | — | 38.5%#6 | — | -216.7%#9 | — | — | -76.5%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice